We could not find any results for:
Make sure your spelling is correct or try broadening your search.
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK1/2 that is in phase 2b clinical t... eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK1/2 that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer (NSCLC). The company is also developing Zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in phase 1/2 clinical trial to treat patients with solid tumors. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. The company was founded in 2012 and is headquartered in San Diego, California. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.11 | -5.26315789474 | 2.09 | 2.13 | 1.92 | 99100 | 1.99837692 | CS |
4 | 0.18 | 10 | 1.8 | 2.34 | 1.6 | 130336 | 1.99492062 | CS |
12 | -9.19 | -82.2739480752 | 11.17 | 17.75 | 1.6 | 404574 | 5.47460033 | CS |
26 | -13.02 | -86.8 | 15 | 17.9 | 1.6 | 1166384 | 11.32768398 | CS |
52 | -13.27 | -87.0163934426 | 15.25 | 37 | 1.6 | 1257352 | 16.5227211 | CS |
156 | -473.02 | -99.5831578947 | 475 | 1010.5 | 1.6 | 777618 | 116.62873264 | CS |
260 | -473.02 | -99.5831578947 | 475 | 1010.5 | 1.6 | 777618 | 116.62873264 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions